Analytical Data
-
基因名
IFM1
- Application
-
别名
IFM1; YOL023WTranslation initiation factor IF-2; mitochondrial; IF-2(Mt); IF-2Mt; IF2(mt)
-
种属
Saccharomyces cerevisiae
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P25038
-
表达区间
43-676aa
-
分子量
97.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IFM1, or Interferon-inducible protein 16 (IFI16), is a critical component of the innate immune response, primarily known for its role in recognizing viral DNA and stimulating antiviral defenses. Recent studies have shown that IFM1 acts not only as a DNA sensor but also plays a significant role in regulating immune responses and inflammation. Its ability to form complexes with various proteins highlights its involvement in signaling pathways that modulate cellular responses to viral infections. Given its importance in the immune system, researchers have focused on the development of recombinant IFM1 proteins to better understand their structure-function relationships and therapeutic potential. By employing recombinant DNA technology, scientists can produce large quantities of IFM1, allowing for in-depth studies of its mechanisms of action and interactions with other cellular components. Additionally, exploring the role of IFM1 in different diseases, including autoimmune disorders and cancers, may provide insights into novel therapeutic approaches. Enhanced understanding of IFM1 through recombinant protein studies could pave the way for innovative strategies in targeting viral infections and modulating immune responses. The ongoing research into IFM1 not only expands our knowledge of the innate immune system but also holds promise for the development of new immunotherapeutic agents that harness its antiviral and regulatory properties.
